Insmed (INSM) Cash from Financing Activities (2010 - 2026)

Insmed's Cash from Financing Activities history runs 17 years deep, the most recent figure standing at $29.5 million for Q1 2026.

• On a quarterly basis, Cash from Financing Activities rose 1.78% year-over-year to $29.5 million in Q1 2026; TTM through Mar 2026 was $954.6 million, a 30.17% decrease from a year earlier, with the FY2025 full-year figure at $954.1 million, down 28.85% from the prior year.
• Cash from Financing Activities retreated to $29.5 million in Q1 2026 per INSM's latest filing, from $33.9 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $857.8 million in Q2 2025 and bottomed at -$399000.0 in Q1 2023.
• The 5-year median for Cash from Financing Activities is $33.9 million (2025), against an average of $193.3 million.
• Across the five-year window, Cash from Financing Activities sank 106.18% in 2023 and jumped 31701.44% in 2024, its largest moves.
• Year by year, Cash from Financing Activities stood at $743.4 million in 2022, then tumbled by 83.42% to $123.3 million in 2023, then gained by 29.24% to $159.3 million in 2024, then sank by 78.75% to $33.9 million in 2025, then slipped by 12.83% to $29.5 million in 2026.
• Per Business Quant, the three latest INSM Cash from Financing Activities figures stand at $29.5 million (Q1 2026), $33.9 million (Q4 2025), and $33.4 million (Q3 2025).